Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

18:42 07/09/2023

Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.

CITIC TELECOM (01883) announces annual financial results, with a net profit attributable to shareholders of HK$920 million, an increase of 1.1% year on year.

BAO PHARMA-B(02659): KJ101 received clinical trial approval for new indications.

SWIRE PROPERTIES (01972) released its annual performance with a net profit attributable to shareholders of HK$8.62 billion, representing a 27% year-on-year increase.

CITIC TELECOM (01883) announces annual financial results, with a net profit attributable to shareholders of HK$920 million, an increase of 1.1% year on year.

BAO PHARMA-B(02659): KJ101 received clinical trial approval for new indications.

SWIRE PROPERTIES (01972) released its annual performance with a net profit attributable to shareholders of HK$8.62 billion, representing a 27% year-on-year increase.